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Abstract
Background:  Male pattern baldness (MPB), an observable trait, has been reported to be
associated with various diseases, such as prostate cancer and cardiovascular disease. Oral sulfur-
containing gases have also been suggested to be useful as markers of systemic health condition.
However, there are no known reports regarding the associations among MPB, and oral sulfur-
containing gases, and systemic health conditions in males.
Methods: We studied 170 male subjects aged either 60 or 65 years old. The degree of MPB was
assessed using the Norwood-Hamilton Baldness scale. Oral sulfur-containing gases were measured
using a compact-designed device. All subjects completed physical and laboratory blood
examinations, a face-to-face medical questionnaire, and an oral examination.
Results: There were significant differences between the levels of CH3SCH3 and baldness patterns,
independent of age. When we analyzed whether the association was linked to systemic health
condition, a strong significant association was observed between the level of CH3SCH3 and severe
MPB in subjects with gastrointestinal diseases, hypertension, and hypercholesterolemia.
Conclusion: These results suggest that MPB is associated with the level of CH3SCH3, a sulfur-
containing gas that causes oral malodor, in elderly Japanese males. Further, the association was
intensified by the existence of gastrointestinal tract and metabolic disorders.
Background
It has been reported that for diagnosis of systemic dis-
eases, male pattern baldness (MPB), a clearly observable
trait, can be used [1,2]. It was also noted that MPB
appeared to be a risk factor for some diseases, for example,
clinical prostate cancer and cardiovascular disease, inde-
pendent of other risk factors, including race and age [3-5].
The precise mechanisms leading to the development of
MPB and such related diseases are largely unknown, how-
ever, they share some epidemiologic and biological risk
factors, including age, heritable genetic factors, and
androgenic metabolism [6,7].
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On the other hand, oral malodor is reported to be prima-
rily associated with dental caries and periodontal disease,
though involvement of other factors including systemic
health conditions and lifestyle have not been ruled out. It
is generally known that volatile sulfur-containing gases,
which mainly consist of the three compounds hydrogen
sulfide (H2S), methanethiol (CH3SH), and dimethyl-
sulfide (CH3SCH3), are responsible for oral malodor [8].
However, it has not been clarified whether these sulfur
gases are derived from the mouth and/or other organs
such as the gut, or how the contents of these gases are
involved with systemic health conditions. Sulfur-contain-
ing molecules in the oral cavity have been used as markers
of various systemic conditions. For example, these sulfur
gases are also present in colonic gas, though colonic con-
centrations are orders of magnitude greater than those in
breath. Since these gases are rapidly absorbed from the
gut, it is possible that they could be transported to the
lungs via the bloodstream and then cleared in expired air,
as is well documented to be the case with H2 and methane
[9]. Colonic H2S and CH3SH in breath could be explained
by an extremely efficient metabolism of these gases by the
colonic mucosa or liver [10]. Further, another study sug-
gested that subjects with chronic liver diseases could be
differentiated from those with normal liver function by
comparing the levels of some sulfur-containing com-
pounds [11]. In contrast, CH3SCH3 is not metabolized by
the colonic mucosa or the liver, and colonic CH3SCH3
might be expected to appear in breath, and Suarez et al.
(2000)[9] suggested that some CH3SCH3 is derived from
the gastrointestinal tract. In addition, Hoshi et al. (2002)
[12] compared sulfur-containing gases between Helico-
bacter pylori-positive and negative patients, and found that
the levels of H2S and CH3SCH3 in mouth air were signifi-
cantly higher in positive patients. Considering that vari-
ous systemic conditions affects breath in the mouth, as
described above, it is possible that MPB has an association
with levels of oral malodor.
The purpose of the present study was to investigate the
severity of MPB in correlation with these sulfur-contain-
ing gases. We also investigated whether systemic health
disorders were linked to changes in the levels of those
gases.
Methods
Recruitment and data collection
This cross-sectional investigation was part of a popula-
tion-based study conducted to investigate the relation-
ships between oral and systemic health. A total of 170
healthy community-dwelling male subjects aged either 60
or 65 years old residing in Fukuoka Prefecture were
recruited in 2006, and all were provided an explanation of
the nature of the research project and provided written
informed consent. The study was also approved by the
Ethics Committee of Kyushu Dental College
(no.05022250).
Each subject completed a questionnaire regarding life-
style, oral and systemic health conditions, and medical
history, and also underwent physical, laboratory blood,
and oral examinations. All current medication usage was
recorded, including treatments for hypertension, diabetes,
and hyperlipidemia. Blood samples were taken after the
subjects had refrained from oral intake and smoking for at
least 2 h before collection, then transported to a commer-
cial laboratory on ice for measurements.
The degree of MPB was assessed in the male subjects using
Norwood-Hamilton Baldness scale [1] by a trained doc-
tor, with hair loss graded progressively from Type I (no
loss) to Type VII (hair loss complete at the crown). For the
purpose of our analyses, subjects with MPB were then
classified to three groups; slight (Type I and II), moderate
(Type III including Type III vertex to V), and severe (Type
VI and VII).
Sampling of oral gases and the devise used
For sampling, subjects were asked to refrain from oral
activity, including eating, drinking, tooth brushing, and
mouthrinsing, before testing. Oral sulfur-containing gases
were measured using an indium oxide (In2O3) semicon-
ductor gas sensor (Oral Chroma, ABILIT, Tokyo, Japan), a
compact-sized device that is popular in dental clinics in
Japan, as described previously [13]. Briefly, subjects were
instructed to keep their mouths closed and breathe
through the nose for 30 s before analysis. A 1-mL dispos-
able syringe was inserted into the oral cavity through the
lips and teeth, and 1 mL of oral air was aspirated by the
syringe. Immediately, 0.5 mL of the sample was injected
into the device. In a previous hospital-based study that
utilized the device (mean subject age, 32.1 years old), ref-
erence values for oral sulfur-containing gases were
reported, as follows: H2S, 358.7 ppb (SE, 25.6); CH3SH,
143.0 ppb (SE, 14.6); CH3SCH3, 19.5 ppb (SE, 2.3) [14].
Statistical analysis
To assess differences between groups, a chi-square test was
used for categorical variables and ANOVA for continuous
variables, followed by adjustment for the effects of age if
necessary. Linear trends for the associations were assessed
by computing the P value for each trend with multiple
regression analysis. All statistical analyses were performed
using SPSS 14.0 for Windows (SPSS Japan, Tokyo, Japan).
The level of statistical significance was set at 0.05 for all of
the analyses.
Results
The prevalence and distribution of MPB in the 170 male
subjects is shown in Table 1. We classified 67 subjects asBMC Public Health 2009, 9:82 http://www.biomedcentral.com/1471-2458/9/82
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slight (39.4%), 64 as moderate (37.6%), and 39 were
severe (23.0%). As shown in Table 2, there were signifi-
cant differences among the groups in regard to age, but
not regarding systemic conditions, including blood pres-
sure and laboratory blood test results, or lifestyle factors of
alcohol use and smoking habit. Medical history for the
subjects revealed 68 with hypertension (of whom 46 were
receiving medication), 25 with diabetes, 10 with CVD, 24
with CHD, 39 with hepatic disease, 15 with respiratory
disease, 79 with gastrointestinal disease, and 26 with
hypercholesterolemia. There were no significant differ-
ences among the groups in regard to medical history.
Table 3 shows the oral health status separated by MPB
group. There was a significant difference only for the level
of CH3SCH3. There were no significant differences
between the ages groups regarding oral sulfur-containing
gases. The mean values for H2S, CH3SH, and CH3SCH3 for
all subjects were 4.64 ng/10 mL (= 346.6 ppb), 2.82 ng/10
mL (= 149.5 ppb), and 0.54 ng/10 mL (= 22.2 ppb),
respectively. We also investigated the effects of systematic
health on CH3SCH3 levels, as shown in Table 4. In the
subjects with gastrointestinal diseases, hypertension
(treated), and hypercholesterolemia, there were signifi-
cant differences among the groups. In particular,
CH3SCH3 in those with severe MPB showed significant
associations with gastrointestinal disease, hypercholester-
olemia, and hypertension (treated) (P for trend < 0.05 for
each), with gastrointestinal disease and hypercholestero-
lemia occurrences shown to be approximately 2 to 5-fold
higher than the level shown in Table 3. A total of 79 sub-
jects had gastrointestinal diseases, which were gastritis in
Table 1: Distribution of the baldness patterns in male subjects
Baldness type N (%)
I 35 (20.6)
II 32 (18.8)
III 26 (15.3)
IV 25 (14.7)
V 13 (7.6)
VI 18 (10.6)
VII 21 (12.4)
Table 2: General characteristics of subjects divided by baldness group
Characteristic Slight Moderate Severe P*
Number of subjects 67 64 39
Age (years) 61.0 (2.1) 61.6 (2.3) 62.7 (2.5) 0.002
Height (cm) 165.9 (5.7) 165.2 (6.5) 163.4 (4.9) 0.11
Weight (kg) 68.0 (9.9) 65.6 (9.7) 64.2 (7.9) 0.10
Body mass index 24.7 (3.1) 23.9 (3.0) 23.9 (2.5) 0.33
Systolic blood pressure (mmHg) 146.2 (16.9) 146.9 (21.6) 144.6 (22.2) 0.86
Diastolic blood pressure (mmHg) 84.3 (10.1) 83.5 (10.0) 84.4 (12.2) 0.88
Serum total cholesterol (mg/dL) 208.3 (34.7) 203.9 (32.9) 208.2 (30.5) 0.72
HDL cholesterol (mg/dL) 57.8 (15.0) 59.5 (16.1) 59.3 (14.2) 0.79
HbA1c (%) 5.30 (0.71) 5.27 (0.73) 5.33 (0.96) 0.93
Estradiol (E2) (pg/mL) 25.7 (6.4) 25.4 (6.1) 25.9 (6.4) 0.92
Testosterone (pg/mL) 13.2 (4.5) 12.7 (3.7) 13.2 (3.9) 0.76
Smoking habit
Never 13 17 13 0.47
Past 36 35 17
Current 18 12 9
Alcohol use
Never 3 7 3 0.66
Light 9 7 4
Moderate 19 13 13
Severe 36 37 19
Medical history
Hypertension 27 27 14 0.67
Diabetes 11 9 5 0.96
CVD 3 5 2 0.70
CHD 6 10 8 0.36
H e p a t i c 1 41 51 00 . 8 3
Respiratory 7 7 1 0.41
G a s t r i c 2 83 12 00 . 5 7
Hypercholesterolemia 15 8 3 0.098
Values indicate number or mean (SD).
CVD: cardiovascular disease; CHD: coronary heart disease.
*Differences between groups were assessed using a chi-square test for categorical variables and an ANOVA for continuous variables.BMC Public Health 2009, 9:82 http://www.biomedcentral.com/1471-2458/9/82
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24, gastric ulcers in 12, duodenal ulcers in 10, gastric can-
cer in 1, large intestine polyps in 11, and combinations of
those gastrointestinal diseases in 21. In contrast, there
were no significant differences among the groups in
regard to subjects treated to eliminate H. pylori. In addi-
tion, in subjects with other systemic diseases such as
hepatic and diabetic diseases, there were no significant
differences among the groups regarding CH3SCH3 levels.
Discussion
In the present cross-sectional study, we investigated com-
munity-dwelling elderly subjects and found a significant
association between CH3SCH3 levels in volatile sulfur-
containing gases and MPB. Further, and the level of
CH3SCH3 was found to be much greater in males with gas-
trointestinal diseases, hypertension, and hypercholestero-
lemia. In general, oral sulfur-containing gases have been
reported to be influenced by systemic conditions [15],
though the number of epidemiological investigations is
limited. A recent study suggested that CH3SCH3 is the
main contributor to extra-oral or blood-borne halitosis,
due to a hitherto unknown metabolic disorder, while
CH3SH and H2S are the main contributors to intra-oral
halitosis [16]. A non-oral etiology of halitosis may include
disturbances of the upper and lower respiratory tracts, dis-
orders of the gastrointestinal tract, metabolic disorders,
and carcinomas [17]. The review has also suggested that
halitosis originating from the respiratory tract is due to
chronic sinusitis, chronic tonsilloliths, or nasal obstruc-
tion, while halitosis originating from the gastrointestinal
tract is due to inflammatory bowel disease, H. pylori infec-
tion, gastritis, and esophageal reflux disease [17]. Most
recently, Zhang et al. suggested that gastrointestinal symp-
toms including halitosis, gastric reflux and abdominal
bloating, is significantly associated with sebaceous gland
diseases (seborrhea, seborrheic dermatitis, acne, androge-
netic alopecia and rosacea) [18], though their study was
based on the questionnaire investigation. In the present
study, we found it interesting that there was no significant
association regarding oral sulfur-containing gases in our
subjects when divided into those with and without gas-
trointestinal diseases (data not shown). Nevertheless,
higher levels of CH3SCH3 were observed in those with gas-
trointestinal diseases. Considering the correlations among
halitosis, gastrointestinal diseases, and sebaceous gland
diseases as described above, it is reasonable that a com-
bined effect of MPB and gastrointestinal disease may lead
to increased CH3SCH3.
Hoshi et al. (2002) [12] compared the levels of oral mal-
odor between H. pylori-positive and -negative patients,
and reported that levels of H2S and CH3SCH3 in mouth air
Table 3: Oral health status of subjects divided by baldness group
Parameter Slight Moderate Severe P**
Number of carious teeth 0.43 (0.9) 0.67 (1.7) 0.69 (1.3) 0.49
Number of missing teeth 5.82 (5.7) 4.19 (4.7) 6.21 (6.7) 0.13
Maximum PD (mm) 4.03 (1.4) 4.17 (1.7) 4.59 (1.5) 0.19
Maximum CAL (mm) 5.32 (1.9) 5.31 (2.3) 5.28 (2.9) 0.99
Number of BOP 3.08 (3.4) 2.86 (3.8) 3.33 (4.3) 0.82
Stimulated salivary flow (mL/min) 1.30 (0.88) 1.37 (0.77) 1.36 (0.66) 0.87
H2S (ng/10 mL) 4.34 (6.7) 4.74 (6.9) 4.99 (7.0) 0.89
CH3SH (ng/10 mL) 2.29 (4.7) 2.56 (4.4) 4.13 (7.3) 0.21
(CH3)2S (ng/10 mL) 0.33 (0.7) 0.27 (0.5) 1.31 (0.3) 0.005
Values indicate mean (SD).
PD: probing depth; CAL: clinical attachment loss; BOP: bleeding on probing.
*Differences between groups were assessed using an ANOVA.
Table 4: Mean values of (CH3)2S in subjects with systemic disease divided by baldness group
Slight Moderate Severe P* P**
Gastrointestinal disease (N = 79) 0.31 (0.80) 0.19 (0.39) 2.26 (4.38) 0.001 0.009
Hypertension (N = 68) 0.47 (0.94) 0.21 (0.35) 0.96 (1.36) 0.02 0.22
Hypertension (treated) (N = 46) 0.27 (0.65) 0.25 (0.39) 1.30 (1.66) 0.007 0.02
Hypercholesterolemia (N = 24) 0.13 (0.36) 0.16 (0.28) 6.50 (11.09) 0.009 0.04
H. pylori elimination (N = 13) 0.45 (0.77) 0.05 (0.08) 0.24 (0.39) 0.43 0.61
Hepatic disease (N = 39) 0.46 (0.80) 0.18 (0.31) 0.59 (1.26) 0.31 0.79
Diabetic disease (N = 25) 0.43 (0.94) 0.12 (0.21) 1.61 (2.91) 0.18 0.24
Values indicate mean (SD) (ng/10 mL).
*P value assessed by ANOVA.
**P value for trend assessed by multiple regression analysis.BMC Public Health 2009, 9:82 http://www.biomedcentral.com/1471-2458/9/82
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were significantly higher in the positive patients. Our
results also showed that levels of CH3SCH3 were lower in
subjects who had received treatment to eliminate H. pylori,
though the difference was below the level of significance.
On the other hand, the levels of H2S were scarcely
changed. Considering that H2S originates from microbial
putrefaction within the oral cavity [16], this finding may
be partly explained by the effect of elimination of H.
pylori, which might be no greater than that of CH3SCH3.
An intervention study is needed to clarify this relation-
ship.
On the other hand, in subjects with hypertension or high
cholesterol, stronger associations between MPB and
CH3SCH3  levels were observed. There are no known
reports regarding associations between halitosis and sys-
temic diseases, such as hypertension and hypercholester-
olemia, whereas several studies have indicated that MPB
may be a risk factor for some diseases, such as CVD or
prostate cancer, though the detailed mechanisms are
unknown [3-5]. One plausible mechanism has been spec-
ulated to be related to sex hormones, such as androgens
[3]. The principal androgen responsible for MPB may be
dihydrotestosterone (DHT), since it is an active metabo-
lite of testosterone produced in tissue by the action of 5α-
reductase, and is involved in the pathogeneses of both
MPB and myocardial infarction [19]. A recent investiga-
tion showed that the level of DHT and ratio of testoster-
one to epitestosterone in vertex hair from premature
baldness subjects were higher than in the sample of non-
baldness subjects [20]. However, we could not clarify the
associations between MPB and levels of sex hormones in
the present study, since the level of DHT was not meas-
ured in our subjects.
Another recent report [21] found an association between
BMI and oral malodor, and suggested that alcohol intake
and BMI may be factors to help predict oral malodor.
High BMI has also been associated with a variety of ail-
ments, including type II diabetes, hypertension, dyslipi-
demia, cerebrovascular accident, myocardial infarction,
cancer (e.g., prostate cancer and colon cancer), gout,
arthritis, fatty liver, and sleep apnea [22]. However, we
found no significant differences among the groups in
regard to height, weight, and BMI. Considering these find-
ings, the association between MPB and oral malodor may
be explained through novel mechanisms that have not
been defined.
There are some limitations to our study. First, the number
of subjects was limited and the results were obtained in a
preliminary research manner. Further, the study subjects
were generally in good health, thus our findings may indi-
cate that an association that exists primarily in healthy
elderly subjects. Finally, because all subjects were Japa-
nese, thus our results may not be applicable to men of
other racial groups.
Conclusion
From this study, within the limitations of the present
study, our results suggest that MPB is associated with an
increased risk of oral malodor independent of age, while
the existence of gastrointestinal disease, and known risk
factors for CVD and CHD (i.e., hypertension and hyperc-
holesterolemia) were found to strengthen association
between MPB and CH3SCH3 levels, though the causes and
effects remain unclarified. Conversely, it is possible that a
subject with higher levels of CH3SCH3 and severe MPB
may be predisposed to gastrointestinal diseases and cardi-
ovascular-related diseases. If so, then assessment of MPB
and measurement of oral malodor, simple and non-inva-
sive methods, may be useful as screening for potential sys-
temic health conditions, including disorders in the
gastrointestinal tract and metabolic disorder, in a large
population-based examination. Nevertheless, additional
research is needed to corroborate these findings and clar-
ify the biological mechanisms related to the increase in
CH3SCH3 levels in subjects with severe MPB.
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